AstraZeneca Withdraws Covid-19 Vaccine Worldwide

Anglo-Swedish drugmaker AstraZeneca  on Wednesday announced the global withdrawal of its Covid-19 vaccine Vaxzevria. Demand for AstraZeneca’s Vaxzevria vaccine began tapering off as new vaccines tailored to specific Covid variants have emerged, the pharmaceutical company said in a statement. The vaccine, developed by AstraZeneca and Oxford University, was produced by the Serum Institute of India (SII) as Covishield.

As multiple variants of Covid-19 vaccines have since been developed, there is a surplus of the available updated vaccines. This has led to a decline in the demand for Vaxzervria, which is no longer being manufactured or supplied,” it said. “Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic,” the statement continued.

AstraZeneca submitted the application to withdraw the vaccine on March 5 and the application came into effect on May 7. The pharma major will make similar applications in the UK and other countries that had approved the vaccine in the coming months.

AstraZeneca said it would now work with regulators and partners to establish a path forward. AstraZeneca in March 2024 voluntarily withdrew its marketing authorization in the European Union, which previously allowed it to promote the vaccine.

Visit our upcoming pharma conferences – https://virtueinsight.com/upcoming-conferences/